Phencyclidine analog use in Sweden - Intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project

Clinical Toxicology

Volumn 53, Issue 9, 2015, Pages 856-864

  Bäckberg, Matilda ^a   Beck, Olof ^b   Helander, Anders ^b  

^a Swedish Poisons Information Centre   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

3 MeO PCP; 4 MeO PCP; Arylcyclohexylamines; Designer drugs; Dissociative drugs; Drug intoxication; Internet drugs; Legal highs; Mass spectrometry methods; New psychoactive substances; NMDA receptor antagonist; Phencyclidine; Research chemicals; STRIDA project

Indexed keywords

3 METHOXY PHENCYCLIDINE; 4 METHOXY PHENCYCLIDINE; DIAZEPAM; HALOPERIDOL; KETAMINE; METHOXETAMINE; MIDAZOLAM; PHENCYCLIDINE; PHENCYCLIDINE DERIVATIVE; PROPOFOL; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; METHOXYDINE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONFUSION; CROSS REACTION; DISORIENTATION; DRUG STRUCTURE; EMERGENCY WARD; FEMALE; HALLUCINATION; HOSPITAL CARE; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; INTOXICATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD REVIEW; MENTAL DISSOCIATION; MENTAL HEALTH; MYDRIASIS; OBSERVATIONAL STUDY; PHENCYCLIDINE INTOXICATION; POISONING SEVERITY SCORE; SCORING SYSTEM; SELF REPORT; SWEDEN; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TANDEM MASS SPECTROMETRY; URINALYSIS; ANALOGS AND DERIVATIVES; BLOOD; DIAGNOSIS; DRUG ABUSE; DRUG OVERDOSE; EPIDEMIOLOGY; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; POISON CENTER; PREDICTIVE VALUE; PROCEDURES; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE; THERAPY; TIME; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHROMATOGRAPHY, LIQUID; DRUG OVERDOSE; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHENCYCLIDINE; PHENCYCLIDINE ABUSE; POISON CONTROL CENTERS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE DETECTION; SWEDEN; TANDEM MASS SPECTROMETRY; TIME FACTORS; YOUNG ADULT;

EID: 84946471849     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2015.1079325     Document Type: Article

References (42)

1. EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). 2015. Available at: http://www.emcdda.europa.eu/attachements.cfm/att-235958-EN-TD0415135ENN.pdf.
2. The Public Health Agency of Sweden. I nformation about the Swedish legislative action on drugs [in Swedish]. Available at: http://www. folkhalsomyndigheten.se/amnesomraden/tillsyn-och-regelverk/klassifi cering-av-missbrukssubstanser/. (Accessed on June, 2015 )
3. Bäckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confi rmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila) 2015; 53: 46-53.
4. Helander A, Bäckberg M, Hultén P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project. Forensic Sci Int 2014; 243: 23-29.
5. Berger ML, Schweifer A, Rebernik P, Hammerschmidt F. NMDA receptor affi nities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl) piperidine enantiomers and of related compounds. Bioorg Med Chem 2009; 17: 3456-3462.
6. Wallach J, De Paoli G, Adejare A, Brandt SD. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues. Drug Test Anal 2014; 6: 633-650.
7. Garey RE. PCP (phencyclidine): an update. J Psychedelic Drugs 1979; 11: 265-275.
8. Anis NA, Berry SC, Burton NR, Lodge D. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 1983; 79: 565-575.
9. Helander A, Beck O, Bäckberg M. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clin Toxicol (Phila) 2015; 53: 446-453.
10. Morris H, Wallach J. From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Test Anal 2014; 6: 614-632.
11. Misselbrook GP, Hamilton EJ. Out with the old, in with the new? Case reports of the clinical features and acute management of two novel designer drugs. Acute Med 2012; 11: 157-160.
12. Helander A, Beck O, Hägerkvist R, Hultén P. Identifi cation of novel psychoactive drug use in Sweden based on laboratory analysis-initial experiences from the STRIDA project. Scand J Clin Lab Invest 2013; 73: 400-406.
13. Persson HE, Sjöberg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36: 205-213.
14. Bäckberg M, Beck O, Hultén P, Rosengren-Holmberg J, Helander A. Intoxications of the new psychoactive substance 5-(2-aminopropyl) indole (5-IT): A case series from the Swedish STRIDA project. Clin Toxicol (Phila) 2014; 52: 618-624.
15. Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 930: 112-120.
16. Johansson M, Fransson D, Rundlöf T, Huynh NH, Arvidsson T. A general analytical platform and strategy in search for illegal drugs. J Pharm Biomed Anal 2014; 100: 215-229.
17. Helander A, Bäckberg M, Beck O. MT-45, a new psychoactive substance associated with hearing loss and unconsciousness. Clin Toxicol (Phila) 2014; 52: 901-904.
18. Kronstrand R, Roman M, Dahlgren M, Thelander G, Wikström M, Druid H. A cluster of deaths involving 5-(2-aminopropyl)indole (5-IT). J Anal Toxicol 2013; 37: 542-546.
19. Kronstrand R, Thelander G, Lindstedt D, Roman M, Kugelberg FC. Fatal intoxications associated with the designer opioid AH-7921. J Anal Toxicol 2014; 38: 599-604.
20. Dominici P, Kopec K, Manur R, Khalid A, Damiron K, Rowden A. Phencyclidine Intoxication Case Series Study. J Med Toxicol 2014. [Epub ahead of print]
21. B luelight. A vailable at: http://www.bluelight.org/vb/content/. (Accessed on June, 2015 )
22. Drug-Forum. Available at: https://drugs-forum.com/forum/index.php. (Accessed on June, 2015 )
23. Erowid. Available at: http://www.erowid.org/. (Accessed on June, 2015 )
24. Flashback. Available at: https://www.fl ashback.org. (Accessed on June, 2015 )
25. EMCDDA. R isk assessments of a various psychoactive substances 1999-2015. Available at: http://www.emcdda.europa.eu/publications/searchresults?action-list & type-PUBLICATIONS & SERIES-PUB-w12. (Accessed on June, 2015 )
26. EMCDDA. European Drug Report 2015: Trends and Developments. 2015. Available at: http://www.emcdda.europa.eu/publications/edr/trends-developments/2015 (Accessed on June, 2015)
27. Beck O, Rausberg L, Al-Saffar Y, Villen T, Karlsson L, Hansson T, et al. Detectability of new psychoactive substances, ' legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Test Anal 2014; 6: 492-499.
28. Reisfi eld GM, Goldberger BA, Bertholf RL. ' False-positive ' and ' false-negative ' test results in clinical urine drug testing. Bioanalysis 2009; 1: 937-952.
29. Schwartz RH. Urine testing in the detection of drugs of abuse. Arch Intern Med 1988; 148: 2407-2412.
30. Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing ' legal highs ' on the Internet-is there consistency in what you get? QJM 2010; 103: 489-493.
31. Bäckberg M, Beck O, Jönsson K-H, Helander A. Opioid intoxications involving butyrfentanyl, 4-fl uorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clin Toxicol (Phila) 2015; 53: 609-617.
32. Läk emedelsverkets fö r teckning Iöv er narkotika (LVFS 2014:11). [ The Medical Products Agency ' s list of provisions on narcotics]. 2014. Available at: https://lakemedelsverket.se/upload/lvfs/LVFS-2014-11.pdf. (Accessed on June, 2015)
33. Stevenson R, Tuddenham L. Novel psychoactive substance intoxication resulting in attempted murder. J Forensic Leg Med 2014; 25: 60-61.
34. Johansson A, Thelander G, Roman M, Lindstedt D, Sandler H, Rubertsson S, et al. Intoxications associated with the novel dissociative drug 3-MeO-PCP (abstract presented at the Nordic Conference on Forensic Medicine. Stockholm, Sweden, June 10-13, 2015).
35. Roth BL, Gibbons S, Arunotayanun W, Huang XP, Setola V, Treble R, et al. The ketamine analogue methoxetamine and 3-and 4-methoxy analogues of phencyclidine are high affi nity and selective ligands for the glutamate NMDA receptor. PLoS One 2013; 8: e59334.
36. Barton CH, Sterling ML, Vaziri ND. Phencyclidine intoxication: clinical experience in 27 cases confi rmed by urine assay. Ann Emerg Med 1981; 10: 243-246.
37. Walberg CB, McCarron MM, Schulze BN. Quantitation of phencyclidine in serum by enzyme immunoassay: results in 405 patients. J Anal Toxicol 1983; 7: 106-110.
38. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981; 10: 290-297.
39. Yago KB, Pitts FN Jr ., Burgoyne RW, Aniline O, Yago LS, Pitts AF. The urban epidemic of phencyclidine (PCP) use: clinical and laboratory evidence from a public psychiatric hospital emergency service. J Clin Psychiatry 1981; 42: 193-196.
40. Bey T, Patel A. Phencyclidine intoxication and adverse effects: A clinical and pharmacological review of an illicit drug. Cal J Emerg Med 2007; 8: 9-14.
41. McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical fi ndings in 1,000 cases. Ann Emerg Med 1981; 10: 237-242.
42. Zawilska JB. Methoxetamine-A novel recreational drug with potent hallucinogenic properties. Toxicol Lett 2014; 230: 402-407.